Similar articles

• Retroviral-mediated gene transfer into mammalian cells.

  Kohn DB, Kantoff PW, Eglitis MA, McLachlin JR, Moen RC, Karson E, Zwiebel JA, Nienhuis A, Karlsson S, O'Reilly R, et al. Kohn DB, et al. Blood Cells. 1987;13(1-2):285-98. Blood Cells. 1987. PMID: 3311223 Review.
• Gene therapy for X-linked immunodeficiencies.

  Kinnon C, O'Reilly MA, Pelham A, Malcolm S, Porter CD, Parkar MH, Collins MK, Leveinsky RJ. Kinnon C, et al. Allergol Immunopathol (Madr). 1991 Jan-Feb;19(1):32-7. Allergol Immunopathol (Madr). 1991. PMID: 1683141 No abstract available.
• Prospects for gene therapy of human disease.

  Blaese RM, Culver KW. Blaese RM, et al. Allergol Immunopathol (Madr). 1991 Jan-Feb;19(1):25-8. Allergol Immunopathol (Madr). 1991. PMID: 1683140 Review. No abstract available.
• Retroviral vector-mediated high-efficiency expression of adenosine deaminase (ADA) in hematopoietic long-term cultures of ADA-deficient marrow cells.

  Bordignon C, Yu SF, Smith CA, Hantzopoulos P, Ungers GE, Keever CA, O'Reilly RJ, Gilboa E. Bordignon C, et al. Proc Natl Acad Sci U S A. 1989 Sep;86(17):6748-52. doi: 10.1073/pnas.86.17.6748. Proc Natl Acad Sci U S A. 1989. PMID: 2549545 Free PMC article.
• Expression of human adenosine deaminase in murine haematopoietic progenitor cells following retroviral transfer.

  Belmont JW, Henkel-Tigges J, Chang SM, Wager-Smith K, Kellems RE, Dick JE, Magli MC, Phillips RA, Bernstein A, Caskey CT. Belmont JW, et al. Nature. 1986 Jul 24-30;322(6077):385-7. doi: 10.1038/322385a0. Nature. 1986. PMID: 3016551